The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Mother-to-child transmission (MTCT) of Human T-cell lymphotropic virus type 1 (HTLV-1)
causes lifelong infection. At least 5–10 million individuals worldwide are currently living with …

The African continent is considered the largest high endemic area for the oncogenic
retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on …

A seroprevalence study was carried out of six different human pathogenic viruses, namely
human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) …

Human T lymphotropic virus 1 (HTLV-1) may be transmitted from mother to child and affects
at least 5–10 million individuals worldwide, with severe consequences on health. Strategies …

Objectives Human T‐lymphotropic virus (HTLV)‐1 causes T‐cell leukaemia and myelopathy.
Together with HTLV‐2, it is endemic in some African nations. Seroprevalence data from …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …

Human T-lymphotropic viruses (HTLV) are Deltaretroviruses that infect millions of individuals
worldwide via the same transmission routes as HIV. With the aim of exposing the possible re …

Infection with human T-cell lymphotropic virus type I (HTLV-I) occurs mainly in Japan,
Central and West Africa and the Caribbean Basin. Although antibody to HTLV-I has been …

To the Editor: The human T-cell lymphotropic virus (HTLV) is endemic in parts of the African
continent, with overall prevalence rates ranging from 0% to more than 10%(1). Most HTLV …